These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 17937416)

  • 1. Development of a novel biocompatible polymer system for extended drug release in a next-generation drug-eluting stent.
    Udipi K; Chen M; Cheng P; Jiang K; Judd D; Caceres A; Melder RJ; Wilcox JN
    J Biomed Mater Res A; 2008 Jun; 85(4):1064-71. PubMed ID: 17937416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel bioabsorbable salicylate-based polymer as a drug-eluting stent coating.
    Jabara R; Chronos N; Robinson K
    Catheter Cardiovasc Interv; 2008 Aug; 72(2):186-94. PubMed ID: 18651646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo performance of a dual drug-eluting stent (DDES).
    Huang Y; Venkatraman SS; Boey FY; Lahti EM; Umashankar PR; Mohanty M; Arumugam S; Khanolkar L; Vaishnav S
    Biomaterials; 2010 May; 31(15):4382-91. PubMed ID: 20189244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymer coatings and delayed arterial healing following drug-eluting stent implantation.
    Byrne RA; Joner M; Kastrati A
    Minerva Cardioangiol; 2009 Oct; 57(5):567-84. PubMed ID: 19838148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pre-clinical assessment of rapamycin-eluting, durable polymer-free stent coating concepts.
    Steigerwald K; Merl S; Kastrati A; Wieczorek A; Vorpahl M; Mannhold R; Vogeser M; Hausleiter J; Joner M; Schömig A; Wessely R
    Biomaterials; 2009 Feb; 30(4):632-7. PubMed ID: 18990438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled delivery of paclitaxel from stent coatings using novel styrene maleic anhydride copolymer formulations.
    Richard R; Schwarz M; Chan K; Teigen N; Boden M
    J Biomed Mater Res A; 2009 Aug; 90(2):522-32. PubMed ID: 18563805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents.
    Byrne RA; Mehilli J; Iijima R; Schulz S; Pache J; Seyfarth M; Schömig A; Kastrati A
    Eur Heart J; 2009 Apr; 30(8):923-31. PubMed ID: 19240066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative spatial distribution of sirolimus and polymers in drug-eluting stents using confocal Raman microscopy.
    Balss KM; Llanos G; Papandreou G; Maryanoff CA
    J Biomed Mater Res A; 2008 Apr; 85(1):258-70. PubMed ID: 17876804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of polymer hydrophilicity on biocompatibility: implication for DES polymer design.
    Hezi-Yamit A; Sullivan C; Wong J; David L; Chen M; Cheng P; Shumaker D; Wilcox JN; Udipi K
    J Biomed Mater Res A; 2009 Jul; 90(1):133-41. PubMed ID: 18491390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mathematical model for predicting drug release from a biodurable drug-eluting stent coating.
    Hossainy S; Prabhu S
    J Biomed Mater Res A; 2008 Nov; 87(2):487-93. PubMed ID: 18186043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymer-Free Drug-Eluting Stents: An Overview of Coating Strategies and Comparison with Polymer-Coated Drug-Eluting Stents.
    Chen W; Habraken TC; Hennink WE; Kok RJ
    Bioconjug Chem; 2015 Jul; 26(7):1277-88. PubMed ID: 26041505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zotarolimus (ABT-578) eluting stents.
    Burke SE; Kuntz RE; Schwartz LB
    Adv Drug Deliv Rev; 2006 Jun; 58(3):437-46. PubMed ID: 16581153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and in vitro release profiles of drug-eluting controlled biodegradable polymer coating stents.
    Pan CJ; Tang JJ; Weng YJ; Wang J; Huang N
    Colloids Surf B Biointerfaces; 2009 Oct; 73(2):199-206. PubMed ID: 19541460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo characterization of novel biodegradable polymers for application as drug-eluting stent coatings.
    Lockwood NA; Hergenrother RW; Patrick LM; Stucke SM; Steendam R; Pacheco E; Virmani R; Kolodgie FD; Hubbard B
    J Biomater Sci Polym Ed; 2010; 21(4):529-52. PubMed ID: 20233507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo changes to PLGA/sirolimus coating on drug eluting stents.
    Xi T; Gao R; Xu B; Chen L; Luo T; Liu J; Wei Y; Zhong S
    Biomaterials; 2010 Jul; 31(19):5151-8. PubMed ID: 20382420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The short-term effects on restenosis and thrombosis of echinomycin-eluting stents topcoated with a hydrophobic heparin-containing polymer.
    Lee YK; Hyung Park J; Tae Moon H; Yun Lee D; Han Yun J; Byun Y
    Biomaterials; 2007 Mar; 28(8):1523-30. PubMed ID: 17157376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-immobilized polymers as non-inflammatory and non-thrombogenic coating materials for arsenic trioxide eluting stents.
    Gong F; Cheng X; Wang S; Zhao Y; Gao Y; Cai H
    Acta Biomater; 2010 Feb; 6(2):534-46. PubMed ID: 19607942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acrylic copolymers as candidates for drug-eluting coating of vascular stents.
    Silvestri D; Cristallini C; Gagliardi M; Barbani N; D'Acunto M; Ciardelli G; Giusti P
    J Biomater Appl; 2009 Nov; 24(4):353-83. PubMed ID: 19033328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using ultrasonic spray nozzles to coat drug-eluting stents.
    Berger HL
    Med Device Technol; 2006; 17(9):44-6, 48-9. PubMed ID: 17240688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal stent design for drug delivery.
    Rogers CD
    Rev Cardiovasc Med; 2004; 5 Suppl 2():S9-S15. PubMed ID: 15184829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.